arrow
R

Renáta Váraljai

university of essen
H指数:15
被引数:641

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The role of KDM5B in creating synthetic vulnerabilities in combination with radiotherapy in melanoma cells

KDM5B在黑色素瘤细胞中与放疗联合作用时创建合成脆弱性的作用

2026-03-050
OAAI
Anti-PD-(L)1 plus BRAF/MEK inhibitors (triplet therapy) after failure of immune checkpoint inhibition and targeted therapy in patients with advanced melanoma

晚期黑色素瘤患者免疫检查点抑制和靶向治疗失败后,抗PD-(L)1联合BRAF/MEK抑制剂 (三联疗法)

2024-05-012
OA
Comprehensive pan-cancer analysis of cfDNA methylation marks in tumors reveals complex epigenetic regulatory circuits and diagnostic biomarkers
2024-03-220
PRE
Interleukin 17 signaling supports clinical benefit of dual CTLA-4 and PD-1 checkpoint inhibition in melanoma (Jul, 10.1038/s43018-023-00610-2, 2023)

白细胞介素17信号支持双重CTLA-4和PD-1检查点抑制在黑色素瘤中的临床益处 (7月,10.1038/s43018-023-00610-2,2023)

2023-08-140
OAAI
Interleukin 17 signaling supports clinical benefit of dual CTLA-4 and PD-1 checkpoint inhibition in melanoma

白细胞介素17信号支持黑色素瘤双重CTLA-4和PD-1检查点抑制的临床益处

2023-07-3117
OAAI
Persister state-directed transitioning and vulnerability in melanoma
2022-06-0119
OAAI
Role of Tumor-Infiltrating B Cells in Clinical Outcome of Patients with Melanoma Treated With Dabrafenib Plus Trametinib
2021-06-096
OAAI
Sequence-dependent cross-resistance of combined radiotherapy plus BRAFV600E inhibition in melanoma
2019-03-0120
PREAI